Research output per year
Research output per year
Personal profile
Expertises
Professor in Clinical Physiology and Nuclear Medicine. Specialist in Clinical Physiology and Nuclear Medicine.More than 260 articles and book chapters on haemodynamic, humoral, and metabolic aspects of chronic liver disease.
"Main research areas
Aspects of Clinical Physiology and Nuclear Medicine and patophysiology. Main research areas are metabolic, humoral, and haemodynamic complications of chonic liver disease, cirrhosis, and portal hypertension. Main research topics include pathophysiology and homeostatic organ-related complications and fluid retention.
Current research
Current research programmes cover studies on changes in pulmonary dysfunction, bacterial translocation and inflammation of cardiac and renal dysfunction in cirrhosis. Pathophysiology and epidemiology relating to cirrhotic cardiomyopathy and investigation of novel biomarkers of renal injury, inflammation, and cardiac dysfunction. Currently, we run protocols relating to acute and chronic haemodynamic effects of betablockers and antibiotics (Rifaximin) on renal function and splanchnic and systemic haemodynamics. Currently, we run studies on haemodymic and humoral effects of intrahepatic shunts (TIPS) in patients with fluid retention and we conduct several prospective studies on cardiac and renal complications developing along with changes in liver dysfunction.
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Søren Møller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis
Wiese, S., Danielsen, K. V., Busk, T., Hove, J. D., Ytting, H., Hansen, S. H., Andersen, K. K., Voiosu, A., Møller, S. & Bendtsen, F., Aug 2023, In: Alimentary Pharmacology and Therapeutics. 58, 4, p. 453-462 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis
Reiniš, J., Petrenko, O., Simbrunner, B., Hofer, B. S., Schepis, F., Scoppettuolo, M., Saltini, D., Indulti, F., Guasconi, T., Albillos, A., Téllez, L., Villanueva, C., Brujats, A., Garcia-Pagan, J. C., Perez-Campuzano, V., Hernández-Gea, V., Rautou, P-E., Moga, L., Vanwolleghem, T., Kwanten, W. J., & 10 others, Feb 2023, In: Journal of Hepatology. 78, 2, p. 390-400 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Association of low mechano-energetic efficiency and prognosis in liver cirrhosis
Sjöstedt, S., Wiese, S., Bendtsen, F. & Møller, S., Jan 2023, In: Clinical Physiology and Functional Imaging. 43, 1, p. 28-32 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Beta-adrenergic blockade in cirrhosis–harmful or helpful?
Møller, S., Danielsen, K. V., Nabliou, P., Kimer, N. & Bendtsen, F., 26 May 2023, (E-pub ahead of print) In: Expert Review of Gastroenterology and Hepatology. p. 1-11 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Changes in weight, body composition and metabolic parameters after switch to dolutegravir/lamivudine compared with continued treatment with dolutegravir/abacavir/lamivudine for virologically suppressed HIV infection (The AVERTAS trial): a randomised, open-label, superiority trial in Copenhagen, Denmark
Pedersen, K. B. H., Knudsen, A., Møller, S., Siebner, H. R., Hove, J. D., Gerstoft, J. & Benfield, T., 21 Aug 2023, In: BMJ Open. 13, 8, p. e075673 e075673.Research output: Contribution to journal › Journal article › Research › peer-review